Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Laser itself helps covid?
View:
Post by Hankerchief on Sep 30, 2020 11:01am

Laser itself helps covid?

Seems interesting.  Add in some TLD 1433 and one has a nice treatment IMO.

Laser for covid?
Comment by Jaro1977 on Sep 30, 2020 11:04am
Nice find Hankerchief, really nice.
Comment by Hankerchief on Sep 30, 2020 11:38am
Looks like this Doc has more to come.  And he is an Ortho doc. Orthoi Doc treating covid related illness with Laser
Comment by Jaro1977 on Sep 30, 2020 11:46am
Nice clip. Here is the full podcast, 9 mins. https://podcasts.apple.com/us/podcast/scott-sigman-founder-chief-medical-officer-at-ortholazer/id1452376188?i=1000490355887 This episode features Scott Sigman, Founder and Chief Medical Officer at OrthoLazer and Host of The Ortho Show podcast. He is also an opioid-sparing Sports Medicine Orthopedic Surgeon.  Here, he discusses his efforts in ...more  
Comment by langosta1 on Sep 30, 2020 11:53am
He should contact UM Dr Coombs
Comment by Jaro1977 on Sep 30, 2020 11:58am
I sent Dr. Coombs the papers and the link to the podcast.  Also sent to TLT management
Comment by Hankerchief on Sep 30, 2020 12:20pm
Good job!  I posted a link to Dr Coombs article on Dr Sigmons page.  Who knows, maybe something can get moving here?
Comment by NeilPaert74 on Sep 30, 2020 12:26pm
Very Cool, so TLT holds tech on both sides of this particular Covid 19 solution.
Comment by Hankerchief on Sep 30, 2020 12:19pm
Funny you should say that.  I posted something on his facebook page aboiut it.
Comment by NeilPaert74 on Sep 30, 2020 12:32pm
I'm sure TLT will happily supply Dr. Coombs with a few specially configured TLC-2xxx or TLC-3xxx. Whichever one is best suited.
Comment by Pandora on Oct 02, 2020 2:01am
Interesting stats re Covid: “We didn’t understand early on what a major risk factor obesity was. … It’s not until more recently that we’ve realized the devastating impact of obesity, particularly in younger people,” says Anne Dixon, a physician-scientist who studies obesity and lung disease at the University of Vermont. That “may be one reason for the devastating impact of COVID-19 in the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250